Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic...

Area of Science:

• Endocrinology
• Urology
• Molecular Biology

Background:

• Prolactin is a key hormone influencing prostate function.
• The long form of the prolactin receptor (PRL-R) is crucial for prolactin signaling.
• Understanding PRL-R expression in the prostate is vital for comprehending its role in health and disease.

Purpose of the Study:

• To investigate the localization and expression patterns of the long form of the human prolactin receptor.
• To compare PRL-R expression in normal prostate tissue across different developmental stages with hyperplastic, dysplastic, and neoplastic lesions.
• To elucidate the role of prolactin signaling in prostate development and cancer progression.

Main Methods:

• In situ hybridization to detect PRL-R messenger RNA (mRNA).
• Immunohistochemistry to visualize PRL-R protein localization.
• Comparative analysis of PRL-R expression in fetal, prepubertal, adult, hyperplastic, dysplastic, and cancerous prostate tissues.

Main Results:

• PRL-R mRNA and protein were primarily found in epithelial cells of normal fetal, neonatal, prepubertal, and adult prostate.
• Receptor expression remained unchanged in hyperplastic prostate tissues compared to normal.
• Markedly enhanced PRL-R expression was observed in dysplastic lesions, irrespective of grade.
• Lower Gleason grade prostate carcinomas showed PRL-R expression similar to normal epithelium.
• Higher grade prostate cancers exhibited diminished PRL-R expression in certain foci.

Conclusions:

• Prolactin signaling is implicated in human prostate development and maintenance.
• Enhanced PRL-R expression in dysplasia suggests a role in early neoplastic transformation.
• Decreased PRL-R in high-grade cancers may indicate a loss of responsiveness to prolactin.